Table 3.
[System Organ Class] Preferred term |
Adverse events
|
Drug-related adverse events
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 mg N=29 |
4 mg N=28 |
12 mg N=26 |
1 mg N=29 |
4 mg N=28 |
12 mg N=26 |
|||||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
Patients with any events | 9 | 31.0 | 8 | 28.6 | 10 | 38.5 | 0 | 1 | 3.6 | 1 | 3.8 | |
[Blood and lymphatic system disorders] | 3 | 10.3 | 1 | 3.6 | 0 | 0 | 0 | 0 | ||||
Anemia | 2 | 6.9 | 1 | 3.6 | 0 | 0 | 0 | 0 | ||||
Nephrogenic anemia | 1 | 3.4 | 0 | 0 | 0 | 0 | 0 | |||||
[Cardiac disorders] | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
Supraventricular tachycardia | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
[Eye disorders] | 0 | 3 | 10.7 | 1 | 3.8 | 0 | 0 | 0 | ||||
Conjunctival hemorrhage | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
Dry eye | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Optic nerve cupping | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Punctate keratitis | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
[Gastrointestinal disorders] | 0 | 2 | 7.1 | 2 | 7.7 | 0 | 1 | 3.6 | 1 | 3.8 | ||
Vomiting | 0 | 1 | 3.6 | 1 | 3.8 | 0 | 1 | 3.6 | 0 | |||
Diarrhea | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Nausea | 0 | 0 | 1 | 3.8 | 0 | 0 | 1 | 3.8 | ||||
[General disorders and administration site condition] | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
Chest pain | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
[Infections and infestations] | 1 | 3.4 | 1 | 3.6 | 1 | 3.8 | 0 | 0 | 0 | |||
Nasopharyngitis | 1 | 3.4 | 0 | 1 | 3.8 | 0 | 0 | 0 | ||||
Pharyngitis | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
[Injury, poisoning, and procedural complications] | 1 | 3.4 | 1 | 3.6 | 1 | 3.8 | 0 | 0 | 0 | |||
Shunt occlusion | 1 | 3.4 | 0 | 0 | 0 | 0 | 0 | |||||
Vascular procedure complication | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Procedural nausea | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
[Investigations] | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
C-reactive protein increased | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
[Musculoskeletal and connective tissue disorders] | 1 | 3.4 | 0 | 0 | 0 | 0 | 0 | |||||
Neck pain | 1 | 3.4 | 0 | 0 | 0 | 0 | 0 | |||||
[Psychiatric disorders] | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Insomnia | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
[Renal and urinary disorders] | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Hematuria | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
[Reproductive system and breast disorders] | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
Breast mass | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
[Respiratory, thoracic, and mediastinal disorders] | 0 | 1 | 3.6 | 1 | 3.8 | 0 | 0 | 0 | ||||
Rhinorrhea | 0 | 0 | 1 | 3.8 | 0 | 0 | 0 | |||||
Upper respiratory tract inflammation | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
[Skin and subcutaneous tissue disorders] | 5 | 17.2 | 2 | 7.1 | 0 | 0 | 0 | 0 | ||||
Dermatitis contact | 4 | 13.8 | 1 | 3.6 | 0 | 0 | 0 | 0 | ||||
Dermal cyst | 0 | 1 | 3.6 | 0 | 0 | 0 | 0 | |||||
Eczema | 1 | 3.4 | 0 | 0 | 0 | 0 | 0 |